- Dynamic changes in vaginal microbiocenosis in the context of diagnosis and treatment of diseases accompanied by vaginal discharge
Dynamic changes in vaginal microbiocenosis in the context of diagnosis and treatment of diseases accompanied by vaginal discharge
HEALTH OF WOMAN. 2020.1(147): 69–72
Medical aspects of women's health. №7-8 (128-129) '2019
REFERENCES
1. Kostin IN, Kuvankina LYu, Simonovskaya HYu. 2013. Mikrobiom cheloveka: nash vtoroy genom. Status Praesens. 11:9-15.
2. Ravel J, Gajer P, Abdo Z et al. 2011. Vaginal microbiome of reproductive age women. 6. Proc Natl Acad Sci USA. 108(Suppl 1):4680-4687.
3. Hickey RJ, Zhou X, Settles ML et al. 2015. Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductiveage women. MBio. 6:2. PMID: 25805726.
4. Bohbot JM, Sednaoui P, Verriere F et al. 2012. The etiologic diversity of vaginitis. Gynecol. Obstet. Fertil. 40:578-581. PMID: 22099980.
5. Lamont RF, Sobel JD, Akins RA et al. 2011. The vaginal microbiome: new information about genital tract flora using molecular based techniques. Br J Obstet Gynaecol. 118(5):533-549.
6. Donders GG, Vereecken A, Bosnians E et al. 2001. Aerobic vaginitis is an entity with abnormal vaginal flora that is distinct from bacterial vaginosis. Int. J. STD AIDS. 12;2:68.
7. Donders GG, Vereecken A, Bosnians E et al. 2002. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 109;1:34-43.
8. Kim SK, Lee JH. 2016. Biofilm dispersion in Pseudomonas aeruginosa. J. Microbiol. 54;2:71-85. Review. PMID:26832663.
9. Rogovskaya SI, Gomberg MA. 2019. Dinamicheskie izmeneniya mikroekosistemyi vlagalischa i lechenie vaginalnyih infektsiy. Zhurnal StatusPraesens 4:59.
10. Rossiyskoe obschestvo akusherov-ginekologov. Klinicheskie rekomendatsii po diagnostike i lecheniyu zabolevaniy, soprovozhdayuschihsya patologicheskimi vyideleniyami iz polovyih putey zhenschin. Izdanie 2-e, ispravlennoe i dopolnennoe. Moskva. 2019. URL: https://www.dna-technology.ru/sites/default/files/rekomendacii_roag. pdf
11. Sherrard J, Wilson J et al. 2018, Nov. European (IUSTI/ WHO) International Union against sexually transmitted infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge. 29(13):1258-1272. doi: 10.1177/0956462418785451. Epub 2018, Jul 27.
12. Zhang X, Li T, Chen X et al. 2018. Nystatin enhances the immune response against Candida albicans and protect the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis. BMC Microbiology 18;1:166. PMID: 30359236.
13. Brotman RM, Shardell MD, Gajer P et al. 2014. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 21;5:450-458. PMID: 24080849.
14. Bohbot JM, Sednaoui P, Verriere F. 2014. Nystatin-neomycin-polymyxin B combination: Efficacy and tolerance as 1st-line local treatment of infectious vaginitis. Open J. Obstet. Gynecol. 4:445-454.
15. Popovski N, Popovski K, Nedelkovski V. 2016. Polygynax in the treatment of vaginal infections in pregnant and non-pregnant women-clinical experience. Akush. Ginekol. (Sofiia). 55;2:3-4. PMID: 27509660.
16. Radzinskiy VE, Ordiyants IM, Pobedinskaya OS i dr. 2016. Opyit primeneniya preparata Polizhinaks v lechenii vulvovaginitov, vyizvannyih aerobnoy i smeshannoy mikrofloroy. Rossiyskiy vestnik akushera-ginekologa 1:84-88.
17. Kira EF i dr. 2010. Biotsenoz i funktsionalnaya aktivnost epiteliya pri mestnom lechenii aerobnogo vaginita Polizhinaksom i Terzhinanom. Zhurnal akusherstva i zhenskih bolezney LIX;5:127-135.
18. Bohbota JM, Goubarda A, Aubinb F et al. 2019. PRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitis. Médecine et Maladies Infectieuses. 49;3:194-201. PMID: 30792037.
19. Hill GB, Eschenbach DA, Holmes KK. 1984. Bacteriology of the vagina. Scand. J. Urol. Nephrol. 86;suppl:23-29.
20. Hill JA, Anderson DJ. 1992. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense function. Am.J. Obstet. Gynecol. 166;2:720-726.
21. Roy R, Tiwari M, Donelli G et al. 2018. Strategies for combating bacterial biofilms: A focus on antibiofilm agents and their mechanisms of action. Virulence. 9;1:522-554. PMID: 28362216.